ApprovalTrail

Drug · DIN 02361043

DIGIFAB

LYOPHILIZED POWDER AND PRESERVATIVE-FREE, SINGLE-USE VIAL

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since November 4, 2011; first marketed November 4, 2011.
Drug Identification Number (DIN)
02361043
Company (DIN owner)
Btg International IncWest Conshohocken, Pennsylvania, United States
Schedule
Schedule D; Prescription
Dosage form
Powder For Solution
Route
Intravenous
Therapeutic class (ATC)
Digitalis antitoxin V03AB24
Class
Human
Record last updated
August 26, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DIGOXIN IMMUNE FAB (OVINE)40 MGVIAL

Notices of Compliance

Health Canada approvals that name this DIN.